Oral pamidronate prevents lumbar spine bone loss in premenopausal female patients suffering from connective tissue disease treated with high doses of glucocorticoids

Nzeusseu, A; Houssiau, Frédéric; Depresseux, Geneviève; Devogelaer, Jean-Pierre

Oral pamidronate prevents lumbar spine bone loss in premenopausal female patients suffering from connective tissue disease treated with high doses of glucocorticoids

Nzeusseu, A

;

Houssiau, Frédéric

;

Depresseux, Geneviève

;

Devogelaer, Jean-Pierre

(2003) 4th European Congress on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ECCEO 4) — Location: NICE (France) (14.November.2003)

Files

No attached file found for this publication.

Details

Authors

Nzeusseu, A
Author
Houssiau, FrédéricUCLouvain
Author
Depresseux, GenevièveUCLouvain
Author
Devogelaer, Jean-PierreUCLouvain
Author

Affiliations

UCLouvainMD/MINT - Département de médecine interne

Citations

APA
Chicago
FWB

Nzeusseu, A., Houssiau, F., Depresseux, G., & Devogelaer, J.-P. (2003). Oral pamidronate prevents lumbar spine bone loss in premenopausal female patients suffering from connective tissue disease treated with high doses of glucocorticoids. Osteoporosis International : with other metabolic bone diseases, 14, S27-S27. https://hdl.handle.net/2078.5/65565 (Original work published 2003)